Departments of Physiology and Pediatrics, The David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1751, USA.
Department of Physiology, The Geffen School of Medicine, UCLA, USA.
Function (Oxf). 2021 Aug 17;2(5):zqab040. doi: 10.1093/function/zqab040. eCollection 2021.
Glucose-galactose malabsorption (GGM) is due to mutations in the gene coding for the intestinal sodium glucose cotransporter SGLT1 (SLC5A1). Here we identify the rare variant Gln457Arg (Q457R) in a large pedigree of patients in the Västerbotten County in Northern Sweden with the clinical phenotype of GGM. The functional effect of the Q457R mutation was determined in protein expressed in oocytes using biophysical and biochemical methods. The mutant failed to transport the specific SGLT1 sugar analog α-methyl-D-glucopyranoside (αMDG). Q457R SGLT1 was synthesized in amounts comparable to the wild-type (WT) transporter. SGLT1 charge measurements and freeze-fracture electron microscopy demonstrated that the mutant protein was inserted into the plasma membrane. Electrophysiological experiments, both steady-state and presteady-state, demonstrated that the mutant bound sugar with an affinity lower than the WT transporter. Together with our previous studies on Q457C and Q457E mutants, we established that the positive charge on Q457R prevented the translocation of sugar from the outward-facing to inward-facing conformation. This is contrary to other GGM cases where missense mutations caused defects in trafficking SGLT1 to the plasma membrane. Thirteen GGM patients are now added to the pedigree traced back to the late 17 century. The frequency of the Q457R variant in Västerbotten County genomes, 0.0067, is higher than in the general Swedish population, 0.0015, and higher than the general European population, 0.000067. This explains the high number of GGM cases in this region of Sweden.
葡萄糖-半乳糖吸收不良(GGM)是由于肠道钠-葡萄糖共转运蛋白 SGLT1(SLC5A1)编码基因的突变引起的。在这里,我们在瑞典北部韦斯特博滕县的一个大型患者家系中发现了罕见的变体 Gln457Arg(Q457R),这些患者具有 GGM 的临床表型。使用生物物理和生化方法,在卵母细胞中表达的蛋白质中确定了 Q457R 突变的功能效应。突变体未能转运特定的 SGLT1 糖类似物α-甲基-D-吡喃葡萄糖苷(αMDG)。Q457R SGLT1 的合成量与野生型(WT)转运体相当。SGLT1 电荷测量和冷冻断裂电子显微镜表明,突变蛋白插入质膜。电生理学实验,无论是稳态还是准稳态,都表明突变体与 WT 转运体相比,结合糖的亲和力较低。结合我们之前关于 Q457C 和 Q457E 突变体的研究,我们确定 Q457R 上的正电荷阻止了糖从外向构象向内向构象的易位。这与其他 GGM 病例中的错义突变导致 SGLT1 向质膜转运缺陷的情况相反。现在,在追溯到 17 世纪后期的家系中,又增加了 13 名 GGM 患者。Q457R 变体在韦斯特博滕县基因组中的频率为 0.0067,高于瑞典总人口的 0.0015,也高于欧洲总人口的 0.000067。这解释了瑞典这一地区 GGM 病例数量较多的原因。